SGLT Inhibition Series

The CardioNerds Cardiovascular Prevention Series brings us into the world of SGLT inhibitors. Initially developed as antidiabetic medications, SGLT inhibitors have been shown to have beneficial effects on cardiovascular and renal outcomes. These benefits result from their on-target glucosuric effects and additional off-target effects. This series will guide us through a comprehensive mechanism for Cardiovascular Disease (CVD) prevention and heart failure management, supported by unrestricted educational sponsorship from Lexicon. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.

SGLT Inhibitors: The Biology of SGLT Inhibition with Dr. Katherine Tuttle

SGLT Inhibitors: The Data Supporting SGLT Inhibition with Dr. Muthiah Vaduganathan

SGLT Inhibitors: Clinical Implementation of SGLT Inhibitors with Dr. Alison Bailey